enGene Therapeutics Inc (ENGN)

Last Closing Price: 1.67 (2026-06-03)

Days Sales in Receivables (Quarterly)

Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover

enGene Therapeutics Inc (ENGN) Days Sales in Receivables data is not available.

Figures for fiscal quarter ending 2026-01-31
Income Statement Financials
--
$-29.75M
--
--
$31.18M
$-31.18M
$1.43M
$-29.75M
$-29.75M
$-29.75M
$-29.75M
$-29.75M
$-29.75M
$-31.18M
$-31.59M
67.26M
67.26M
$-0.44
$-0.44
Balance Sheet Financials
$289.22M
$2.44M
$47.90M
$337.11M
$24.61M
$24.74M
$30.96M
$55.57M
$281.55M
$281.55M
$281.55M
66.99M
Cash Flow Statement Financials
$-28.90M
$-126.30M
$141.66M
$50.15M
$36.61M
$-13.54M
$2.80M
--
--
Fundamental Metrics & Ratios
11.75
--
--
0.08
0.09
--
--
--
--
--
--
$-29.06M
--
--
--
--
--
--
Days Sales in Receivables
--
-10.57%
-10.57%
-8.83%
-9.71%
$4.20
$-0.43
$-0.43